Overactive Bladder
📧 Sign up to get email alerts when something new happens for Overactive Bladder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Comparison of Posterior Tibial Nerve Electrical Stimulation Protocols for Overactive Bladder Syndrome [NA]
A completed clinical trial comparing different posterior tibial nerve electrical stimulation protocols for treating overactive bladder.
-
CLINICAL_TRIALS research · 2019-02-04Clinical Trial Update: The Clinical Effects of Laser Acupuncture Therapy for OAB Women. [NA]
A clinical trial is evaluating the effects of laser acupuncture therapy for women with overactive bladder; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2019-01-18Clinical Trial Update: Prevalence and Risk Factors Nocturnal Polyuria in Female OAB
Completed clinical trial from National Taiwan University Hospital examining how common nocturnal polyuria is in women with overactive bladde…
-
CLINICAL_TRIALS trial_result · 2018-12-24Clinical Trial Update: Postmarketing Study to Evaluate add-on Therapy With Anticholinergics in Patients With Overactive Bladder (OAB) on Mirabegron. [Phase 4]
Phase 4 postmarketing study evaluating add-on anticholinergic therapy in patients with overactive bladder who are on mirabegron; completed w…
-
CLINICAL_TRIALS trial_result · 2018-12-12Clinical Trial Update: PRospective Study to Evaluate EffectivenesS With the NURO™ PErcutaneous Tibial Neuromodulation System in Patients With OAB [NA]
A completed clinical trial evaluating effectiveness of the NURO percutaneous tibial neuromodulation system for overactive bladder; results p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-12-12Clinical Trial Update: Evaluation of Botulinum Toxin A Alone Versus Botulinum Toxin A With Hydrodistension for Treatment of Overactive Bladder [NA]
Clinical trial comparing botulinum toxin A alone versus botulinum toxin A with hydrodistension for overactive bladder; study terminated with…
-
CLINICAL_TRIALS trial_result · 2018-11-26Clinical Trial Update: Instillation of Botox in the Bladder in Women With Overactive Bladder (OAB) [Phase 2]
Phase 2 clinical trial evaluating intravesical botulinum toxin (Botox) for overactive bladder in women, completed.
-
CLINICAL_TRIALS trial_result · 2018-09-20Clinical Trial Update: Reduction of Bladder Injection Pain With Belladonna Opiate Suppository [Phase 4]
Phase 4 clinical trial assessing reduction of bladder injection pain with Belladonna opiate suppository in overactive bladder and related co…
-
CLINICAL_TRIALS trial_result · 2018-09-18Clinical Trial Update: A Phase 4 Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With Overactive Bladder (OAB) Symptoms, While Taking the Alpha Blocker for Benign Prostatic Hypertrophy (BPH) [Phase 4]
Phase 4 study evaluating efficacy, safety, and tolerability of mirabegron in men with overactive bladder who are taking an alpha-blocker for…
-
FDA approval · 2018-09-06FDA Approved: OXYBUTYNIN CHLORIDE — Original Application (TruPharma LLC)
The FDA approved an Original Application for oxybutynin chloride from TruPharma LLC. This is a generic formulation for the treatment of over…
-
CLINICAL_TRIALS trial_result · 2018-08-24Clinical Trial Update: Comparison of Solifenacin and Mirabegron in Treatment of Overactive Bladder Symptoms in Men After TURP [Phase 2]
A Phase 2 trial comparing solifenacin and mirabegron for overactive bladder symptoms in men after TURP.
-
CLINICAL_TRIALS trial_result · 2018-08-14Clinical Trial Update: Interventional Clinical Trial in Patients in Overactive Bladder With Nocturia in Women [Phase 2]
Phase 2 interventional trial in women with overactive bladder and nocturia has completed; results posted in 2018.
-
CLINICAL_TRIALS research · 2018-07-30Clinical Trial Update: Epidemiology of Urinary Functional Disorders in Women of 40 and More
A completed clinical trial update studying the epidemiology of urinary functional disorders in women aged 40 and older, focusing on the role…
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: The Use of cineMRI to Evaluate Botox in Patients With Medication Refractory Overactive Bladder [NA]
A clinical trial update investigating cineMRI to evaluate the effect of Botox (onabotulinumtoxinA) in patients with medication-refractory ov…
-
FDA approval · 2018-07-13FDA Approved: DETROL LA — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Detrol LA (tolterodine tartrate) submitted by Viatris Specialty LLC.
-
CLINICAL_TRIALS withdrawal · 2018-07-12Clinical Trial Update: Use of Biotene Moisturizing Mouth Spray for Xerostomia Associated With Oral Oxybutynin Use [Phase 4]
Phase 4 trial evaluating Biotene Moisturizing Mouth Spray for xerostomia associated with oral oxybutynin use has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-06-26Clinical Trial Update: Comparisons of Urodynamic, Bladder Diary, Quality of Life Parameters Between OAB-wet and OAB-dry Female Patients
Clinical trial comparing urodynamic measures, bladder diaries, and quality of life between women with overactive bladder who have urgency in…
-
CLINICAL_TRIALS trial_result · 2018-06-20Clinical Trial Update: Pilot Study of Mirabegron in Pediatric Patients With Overactive Bladder [Phase 3]
Phase 3 pilot study evaluating mirabegron for overactive bladder in pediatric patients has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2018-06-19Clinical Trial Update: Efficacy and Safety of the Mirabegron Compared With Solifenacin in Treatment of Overactive Bladder [Phase 4]
A Phase 4 trial evaluated the efficacy and safety of mirabegron compared with solifenacin for overactive bladder, and the study has complete…
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: This Was a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder [Phase 3]
Phase 3 multinational trial evaluating the efficacy and safety of combining solifenacin succinate with mirabegron versus each drug alone or …
-
CLINICAL_TRIALS withdrawal · 2018-06-08Clinical Trial Update: Autologous Neo-Bladder Construct in Non-Neurogenic Overactive Bladder and Urge Predominant Incontinence [Phase 2]
A Phase 2 clinical trial evaluating an autologous neo-bladder construct for non-neurogenic overactive bladder with urge incontinence has bee…
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, in Subjects With Symptoms of Overactive Bladder [Phase 3]
A multinational Phase 3 trial evaluated long-term efficacy and safety of taking solifenacin succinate and mirabegron together versus each dr…
-
CLINICAL_TRIALS other · 2018-06-04Clinical Trial Update: Training and Counseling Program for Overactive Bladder Treatment [NA]
A Biruni University-sponsored trial evaluating a training and counseling program for overactive bladder has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: Efficacy of Different Electrical Stimulation Placement in Patients With Overactive Bladder Syndrome [NA]
An update on a clinical trial evaluating different electrical stimulation placements for efficacy in overactive bladder syndrome.
-
CLINICAL_TRIALS trial_result · 2018-05-09Clinical Trial Update: Use of Medium Frequency Electrotherapy in the Treatment of OAB, LUTS and Pelvic Pain [NA]
This entry notes the completed status of a trial evaluating medium frequency electrotherapy for overactive bladder, lower urinary tract symp…